Fasenra and Nucala: Approved Therapies for EGPA

Join us for this exciting, live webinar led by Peter Merkel, MD, MPH. Dr. Merkel is the Chief of the Division of Rheumatology and Professor of Medicine and Epidemiology at the University of Pennsylvania. The webinar will focus on two drug studies for eosinophilic granulomatosis with polyangiitis (EGPA).